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Abstract
The aim of research was to reveal the dynamic changes of the level of excitatory and inhibitory neuroamino acids in patients 
with the primary cerebral ischemic stroke depending on postapoplectic spasticity presence at the end of the early recovery period. 
For this aim was studied the concentration of excitatory and inhibitory neuroamino acids in the blood plasma in first 72 hours 
in 97 patients with the primary ischemic cerebral stroke depending on postapoplectic spasticity on the sixth month after ischemic 
event. The control group included 15 patients with diagnosed chronic cerebral ischemia. 
In the result of research we revealed that the common sign for the two groups (with spasticity on the sixth month and without 
it) was the reliable rise of the level of excitatory amino acids comparing with the control. In patients without spasticity the heightened 
level of excitatory neurotransmitters in the most acute period of ischemic cerebral stroke was attended with the heightened level 
of inhibitory neuroamino acids.  The distinctive feature of patients with postapoplectic spasticity was the decreased or stable level 
of transmitters of inhibitory action. During 6th moth after ischemic stroke was detected the rise of all studied neuroamino acids in 
patients with spasticity unlike to the ones without spasticity who were characterized only with the rise of taurine level and decrease 
of glycine and aspartate levels. 
So, the received results allow assume the insufficient activation of the inhibitory neuroamino acids system in the most acute 
period of the ischemic stroke in certain category of patients that in future are inclined to the spasticity development after stroke. 
Keywords: primary cerebral ischemic stroke, excitatory and inhibitory neurotransmitters, most acute period, early recovery 
period, postapoplectic spasticity. 
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1. Introduction
Last few years the results of numerous researches proved the significant role of excitatory 
neuroamino acids in the acute and delayed destruction of neurons [1]. The information from the 
literature data about amino acid spectrum of the blood of patients with the acute ischemic stroke 
is insufficient and full of contradictions. Thus, in the study of Butter Th. et al. [2] the authors re-
vealed the rise of glutamate concentration in the first 24 hours after ischemic stroke with its further 
decrease that was not observed at the study of glycine level. Some authors state that the decrease of 
glutamate level in blood plasma connected with the compensatory rise of GABA at the increased 
aspartate level [3]. Several researchers proved the rise of glutamate acid level and decrease of gly-
cine and proline levels in patients in the acute period of ischemic stroke [4, 5]. 
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In 40 % of synapses of brain and spinal cord the main transmitters are excitatory amino 
acids aspartate and glutamate [6–8]. In the both pyramidal and cerebellar tracts are present the glu-
tamatergic neurons [9]. The main inhibitory transmitter of CNS is GABA. GABA-ergic influence 
on the spinal motor centers is realized through the red kernel spinal, vestibular spinal tracts [6, 10]. 
The main inhibitory spinal transmitter is glycine [11–13]. The significant role in spasticity 
development belongs also to the blue spot – descendent monoaminoergic system where commence 
the descendent norandrenergic fibers that go in the content of pyramidal tract and end in the grey 
substance of the spinal cord on the motoneurons of the front horns [14, 15]. 
The Frosini’s et al. research and other ones carried out by the American scientists [16, 17] 
disclosed the certain type of receptors familiar by the biochemical structure to the taurine com-
pound (GABA, glutamate, glycine)  that have neither  agonistic nor antagonistic effect. That is 
why such type of receptors is considered as taurine receptors and taurine as such as the inhibitory 
neurotransmitter.  
Taking into account the multi-vector of the scientific data about the content of neurotrans-
mitters in the blood plasma of patients with ischemic stroke and the aforesaid information about 
their influence of the formation of spastic muscular hypertonus the subject of research is the 
content of excitatory (glutamate, glutamine acid, aspartate, aspartic acid and tyrosine as the 
predecessor of noradrenalin) and inhibitory (GABA, glycine, taurine) amino acids of the blood 
plasma of patients with the primary ischemic stroke depending on the postapoplectic spasticity 
in the early recovery period. 
2. Aim of research 
To study the dynamic changes of the level of excitatory and inhibitory neuroamino acids 
in patients with the primary cerebral ischemic stroke depending on the presence of postapoplectic 
spasticity at the end of the early recovery period. 
3. Materials and methods
There were examined 97 patients with ischemic stroke in the most acute period (1–3 day) 
and at the end of the early recovery (sixth month) period, which were at the stationary treatment in 
1st and 2 neurological departments of the Municipal city clinical hospital of the Lviv ambulance. 
The ischemic stroke was diagnosed in all patients using computed tomography. Among patients 
were 51 men and 46 women, mean age was 60,13±0,92 years (mean age for men– 60,62±1,38, 
for women – 59,58±1,21 years). The muscular tonus was assessed on the 6th month after ischemic 
stroke using the modified Ashworth scale according to which (taking into account the common 
rules of its use) the tonus rise at MAS≥1 is considered as spasticity [18]. Depending on presence of 
postapoplectic spasticity at the end of the early recovery period 2 groups of patients were formed. 
The group of patients with spasticity included 48 patients (in 32 ones was revealed the spasticity on 
hemitype and in 16 the spasticity was only in hand) and the group of patients without spasticity – 
49 persons. The group of control was formed by 15 patients with the chronic ischemia of brain (8 
men and 7 women). The mean age of patients of the control group was 60,27±1,82 (mean age for 
men was 59,75±2,81, for women – 60,86±2,41).
For the study was taken 5 ml of blood from the cubital vein two-time fasting: during the 
first 72 hours after the primary ischemic stroke and on the 6th month – at the end of the early re-
covery period. For studying the amino acid blood spectrum was taken plasma and measured the 
concentration using the automatic amino acid analyzer LC 6001 Biotronic (Germany). The study of 
neuroamino acids concentration was carried out in laboratory of the molecular biology and clinical 
biochemistry of the Lviv institute of animal biology. 
The statistical processing of data was carried out using the «Exсel» program from Windows 
2007 package and «Statistica-10» program using the methods of describing statistics for calculation 
of the median, lower and upper quartiles and determination of the reliable difference for non-para-
metric values by the Mann-Whitney method. The results were presented as Me [LQ; UQ]. The data 
were considered as the reliable ones at p<0,05. 
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4. Results
In the Table 1 are presented the data of the content of excitatory and inhibitory neurotrans-
mitters in the blood plasma of patients with the ischemic stroke in the most acute period and the 
content of the same amino acids in the control group. Patients with the ischemic stroke were divid-
ed in two groups depending on formation of postapoplectic spasticity on the 6th month after acute 
ischemic event. 
Table 1
Neuroamino acid concentration in patients in the most acute period of PCIS with spasticity on 
the 6th month and without it 
Parameter
Group of patients
Control group Without spasticity  With spasticity 
Glutamate, mcM/l 82,1 [75,5; 87,7]
173,3 [144,3; 210,0]
p0<0,01
240,8 [205,0; 285,1]
p0<0,01
p1<0,01
Glutamine, mcM/l 487,9 [430,3; 510,8]
505,3 [480,1; 520,4]
p0>0,05
1087,9 [950,1; 1309,8]
p0<0,01
p1<0,01
Aspartate, mcM/l 153,2 [143,1; 168,2] 215,7 [197,5; 235;1]p0<0,01
321,2 [287,5; 342,7]
p0<0,01
p1<0,01
Asparagine, mcM/l 53,6 [49,6; 57,9] 66,8 [58,3; 75,6]p0<0,05
56,6 [54,5; 58,7]
p0>0,05
p1<0,01
Tyrosine, mcM/l 54,7 [50,1; 59,9] 49,6 [41,2; 52,4]p0<0,01
46,7 [40,3; 50,8]
p0<0,01
p1>0,05
GABA, mcM/l 2,8 [2,5; 3,4] 10,0 [8,7; 11,7]p0<0,01
3,4 [2,6; 4,1]
p0>0,05
p1<0,01
Glycine, mcM/l 185,0 [178,3; 189,9] 277,8 [245,7; 301,7]p0<0,05
70,1 [55,8; 81,1]
p0<0,01
p1<0,01
Taurine, mcM/l 27,9 [24,7; 30,3] 17,0 [16.2; 18,7]p0<0,05
13,6 [12,1; 15,6]
p0<0,05
p1<0,05
Glutamate/GABA 30,0 [21,9; 34,1] 17,1 [14,7; 19,9]p0<0,01
74,5 [55,7; 102,7]
p0<0,01
p1<0,01
Notes: p0 – probability of differences comparing with the control group; p1 – probability of differences comparing with 
patients without postapoplectic spasticity
In the Table 2 are presented the excitatory and inhibitory neuroamino acids in the blood 
plasma at the end of the early recovery period depending on presence of postapoplectic spasticity. 
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Table  2
Neuroamino acids concentration in patients in the PCIS recovery period with spasticity on the 
6th month and without it 
Parameter
Group of patients
Control group Without spasticity With spasticity 
Glutamate, mcM/l 82,1 [75,5; 87,7]
86,7 [83,7; 91,7]
p0>0,05
168,3 [157,9; 199,3]
p0<0,01
p1<0,01
Glutamine, mcM/l 487,9 [430,3; 510,8]
500,1 [480,8; 510,4]
p0>0,05
693,6 [551,5; 755,4]
p0<0,01
p1<0,05
Aspartate, mcM/l 153,2 [143,1; 168,2]
105,8 [91,1; 123,2]
p0<0,01
189,7 [166,2; 237,8]
p0<0,05
p1<0,01
Asparagine, mcM/l 53,6 [49,6; 57,9] 72,5 [65,9; 80,2]p0<0,01
65,2 [59,8; 70,6]
p0<0,05
p1<0,05
Tyrosine, mcM/l 54,7 [50,1; 59,9] 58,8 [53,2; 62,3]p0>0,05
79,9 [77,3; 87,6]
p0<0,05
p1<0,05
GABA, mcM/l 2,8 [2,5; 3,4] 3,3 [2,7; 3,8]p0>0,05
11,5 [9,5;13,0]
p0<0,01
p1<0,01
Glycine, mcM\l 185,0 [178,3; 189,9]
120,2 [107,7; 157,9]
p0<0,05
232,7 [193,1; 302,7]
p0<0,01
p1<0,01
Taurine, mcM/l 27,9 [24,7; 30,3] 82,1 [75,5; 87,8]p0<0,01
53,9 [44,7; 70,2]
p0<0,01
p1<0,05
Glutamate/GABA 30,0 [21,9; 34,1] 25,9 [22,3; 32,6]p0>0,05
16,8 [12,7; 19,8]
p0<0,01
p1<0,01
Notes: p0 – probability of differences comparing with the control group; p1 – probability of differences comparing with 
patients without postapoplectic spasticity 
5. Discussion of the results of research
At comparison of the level of excitatory neurotransmitters in the most acute period of PCIS 
the common sign for two groups of patients with postapoplectic spasticity in the one group of 
muscles on the 6th month and without it was revealed the reliable increase of glutamate (p<0,01) 
and aspartate (p<0,01) levels comparing with the control group (Table 1). At that in the group of 
patients with spasticity the concentration of these neurotransmitters grew mainly with exceed by 
32 % as to glutamate level and by 33 % – aspartate one. The common sign for two groups of pa-
tients was also the reliable decrease of tyrosine level (p<0,01) comparing with the control group. 
The distinctive feature in the group of patients with PAS was the significantly higher concentration 
of glutamine level and as opposite to the group of patients without spasticity it was the statistically 
significant difference comparing with the control group (p<0,01). An interesting feature was the 
fact that unlike patients with spasticity on the 6th month after PCIS in the group of patients without 
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spasticity the asparagine level mainly increased and it was statistically reliably comparing with the 
control group (p<0,05) (Table 1). 
It must be noted that in the most acute period of PCIS were revealed also the differences 
as to the inhibitory neurotransmitters concentration between the group of patients with spasticity 
on the 6th month and without it. Thus, in patients without PAS the GABA level grew much more 
significantly and exceeded concentration in 2,9 times comparing with the control group (p<0,01), 
while in the group of patients with PAS the exceed of the level of control group was in 1,3 times 
(p>0,05). An interesting feature was the difference of the glycine level which concentration in the 
group of patients without PAS had the tendency to increase and exceeded the value of the control 
group by 49 % (p>0,05), and in the group of patients with PAS reliably decreased as to the group 
of control (p<0,01) and group of patients with spasticity (p<0,01). The taurine level in the most 
acute period of stroke was reliably decreased in both groups of patients (p<0,05). The generalized 
results of the study of excitatory and inhibitory neurotransmitters level in the most acute period of 
ischemic stroke are presented in the Table 1.
During the 6th month after PCIS the reliably higher level of excitatory neuroamoni acids was 
revealed in patients with PAS comparing with patients without spasticity and the control group. So, 
the glutamate level measured in patients with PAS exceeded the values in patients without spastic-
ity by 95 % (p<0,01), glutamine – by 38 % (p<0,05) aspartate by 80 % (p<0,01) tyrosine by 36 % 
(p<0,05). The single exception is the value of asparagine content which level was by 11 % higher 
in the group of patients without spasticity (p<0,05). At the same time the glutamate, glutamine and 
tyrosine concentration in patients without spasticity did not have the statistically significant dif-
ference comparing with the control (p>0,05). In the same group of patients the revealed aspartate 
level was reliably higher than in the control one and asparagine level was lower, so, we can make a 
conclusion about the activation of process of aspartate biotransformation into asparagine in these 
patients [19] (Fig. 1).
Fig. 1. Asparagine biosynthesis
As to the concentration of inhibitory neurotransmitters must be noted the significantly high-
er values of GABA and glycine levels in patients with spasticity that was statistically significant 
comparing with group without PAS (p<0,01 for glutamate and glycine) and the control one (p<0,01 
for glutamate and glycine). In patients without spasticity the GABA concentration did not statisti-
cally differ from the control value and glycine level was reliably lower (p<0,05). Taurin was char-
acterized with an increase of its level in both groups comparing with control but unlike GABA and 
glycine its concentration was higher in patients without spasticity. Taking into account the gluta-
mate\GABA ratio, it must be noted, that its value in patients without spasticity did not reliably differ 
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from the one in the control group (p>0,05), and in patients with PAS it was lower comparing with 
the control value, that was statistically significant (p<0,01). The results of the study of excitatory 
and inhibitory neurotransmitters level at the end of the early recovery period of ischemic stroke are 
presented in the Table 2. 
So, the analysis of the received data demonstrated the activation of excitatory neurotrans-
mitters system in both groups on 1–3 day after ischemic stroke and decrease of activity of the 
inhibitory transmitters system in patients with PAS at the end of the early recovery period. In the 
group of patients without spasticity in any muscular group took place an activation of the inhibi-
tory transmitters (GABA, glycine) system as a response on the surplus concentration of excitatory 
neuroamino acids. Taking into account the received results and biochemical features of GABA- 
bypass [20] (Fig. 2) we can make an assumption about the certain compensatory mechanisms of 
biotransformation of the glutamate surplus into GABA in certain category of patients with isch-
emic stroke that to some extent prevent the spasticity development. 
Fig. 2. GABA-bypass
So, if calculate the glutamate/GABA ration, in the control group it was 30,0 [21,9; 34,1], and 
in the group of patients with PAS and without it 74,5 [55,7; 102,7] and 17,1 [14,7; 19,9] respective-
ly, that was statistically significant comparing with the control group (p<0,01) and between two 
groups of patients who underwent PCIS (p<0,01). Summing up the results received during the 6th 
month after stroke we can make a conclusion about the presence of “neurotransmitter strain” in 
patients with developed postapoplectic spasticity.  
6. Conclusions
1. The revealed insufficiency of the amino acid inhibitory system in the most acute period of 
ischemic stroke in the certain category of patients who in the further were inclined to the spasticity 
development can be used for the screening of such patients for the early rehabilitation. 
2. The research needs the special attention for the further study of the possibility of correc-
tion of insufficiency of the inhibitory neuroamino acids system in the most acute period of ischemic 
stroke in patients who need it. 
3. The revealed differential features of the neuroamino acid spectrum of blood plasma of pa-
tients in the most acute period of stroke can be used for elaboration of the model of prognostication 
of the postapoplectic spasticity formation. 
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